Applied Cancer Research

Table 3 Odds ratio for patients with positive EGFR expression

From: Prognostic utility of epidermal growth factor receptor (EGFR) expression in prostatic acinar adenocarcinoma

		odds ratio(95% CI)	P-Value
Total gleason score	6	0.026(0.003–0.219)	0.001
	7	0.115(0.028–0.471)	0.003
	8	0.227(0.067–0.771)	0.017
	9®	1
WHO grade group	Grade-1	0.026(0.003–0.219)	0.001
	Grade-2	0.087(0.017–0.441)	0.003
	Grade-3	0.333(0.031–3.606)	0.333
	Grade-5	0.227(0.067–0.771)	0.017
	Grade-5®	1	0.001
Tumor Quantification	< 10%	0.110(0.014–0.876)	0.037
	10–50%	0.227(0.062–0.832)	0.025
	> 50%®	1
Perineural invasion	Present	5.333(1.990–14.293)	0.001
Perineural invasion	Absent®	1
Recurrence	Yes	29.17(8.63–98.55)	< 0.001
	No®	1

Univariate binary logistic regression was applied
®Reference Category

Back to article page